2-((1'-Acetyl-4-oxospiro[chromane-2,4'-piperidin]-7-yl)oxy)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide

Catalog No. :
ACEVOA676
CAS No. :
1214625-48-5
Molecular Formula :
C27H30N2O5
Molecular Weight :
462.55

IUPAC Name:2-((1'-acetyl-4-oxospiro[chromane-2,4'-piperidin]-7-yl)oxy)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide

2-((1'-Acetyl-4-oxospiro[chromane-2,4'-piperidin]-7-yl)oxy)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((1'-Acetyl-4-oxospiro[chromane-2,4'-piperidin]-7-yl)oxy)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide
IUPAC Name2-((1'-acetyl-4-oxospiro[chromane-2,4'-piperidin]-7-yl)oxy)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide
Molecular FormulaC27H30N2O5
Molecular Weight462.55
SMILESO=C(NC1CCCC2=C1C=CC=C2)COC3=CC4=C(C=C3)C(CC5(CCN(C(C)=O)CC5)O4)=O
InChI KeyFHRQRCOQYAVRNL-UHFFFAOYSA-N
Synonym2-(1'-acetyl-4-oxospiro[3H-chromene-2,4'-piperidine]-7-yl)oxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide;Acetamide, 2-[(1'-acetyl-4-oxospiro[2H-1-benzopyran-2,4'-piperidine]-7(3H)-yl)oxy]-N-(1,2,3,4-tetrahydro-1-naphthalenyl)-
CAS No.1214625-48-5

Synthetic Route by SureRoute

1. ACEVOA676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEVOA676 route product structure diagram
    ACEVOA6761214625-48-5
Inquiry

2. ACEVOA676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFNVY392 route compound structure diagram
    ACFNVY3923459-02-7 In Stock
  4. Then
  5. ACEVOA676 route product structure diagram
    ACEVOA6761214625-48-5
Inquiry

Comments (0)